Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02338102 · ClinicalTrials.gov registry record · NA
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer
A NA study of Epistaxis and Nasal Obstruction, sponsored by Lisa Shnayder.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT02338102: Completed NA study of Epistaxis and Nasal Obstruction, sponsored by Lisa Shnayder.
NCT02338102 is a NA study of Epistaxis and Nasal Obstruction that has completed, run by Lisa Shnayder. The registered enrollment target is 36 participants, below the 2,540-participant average among 4 other Epistaxis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02338102, a NA study of Epistaxis and Nasal Obstruction, has completed, sponsored by Lisa Shnayder.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn whether nasal saline irrigation is beneficial to patients undergoing radiation therapy for oropharyngeal cancer.
Primary Outcome
Outcome measured using Sino-Nasal Outcome Test (SNOT-20) summary scores. Scores will be collected at the baseline visit and again on the Month 2 visit. Outcome represented as a change in mean summary scores between the two visits. Scores can range from 0-5 with 0 being the best and 5 being the worst.
Conditions Studied
Interventions
- OTHER Saline mixture
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-05 |
| Phase | NA |
What the finished NCT02338102 record still lists
NCT02338102 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 2,540-participant average among 4 other Epistaxis trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Epistaxis appearing as the primary indexed condition, and to 1 intervention - of which Saline mixture is the first listed.
NCT02338102 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT02338102 about?
NCT02338102 is a clinical study titled "Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer". The purpose of this study is to learn whether nasal saline irrigation is beneficial to patients undergoing radiation therapy for oropharyngeal cancer.
What is the current status of trial NCT02338102?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2013-01. Estimated completion is 2015-05.
What conditions does trial NCT02338102 study?
This clinical trial studies the following conditions: Epistaxis, Nasal Obstruction, Rhinitis, Vasomotor.
What interventions are being tested in trial NCT02338102?
The interventions under investigation include: Saline mixture (OTHER).
Who is sponsoring clinical trial NCT02338102?
This trial is sponsored by Lisa Shnayder, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02338102 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epistaxis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
, "Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?"
COMPLETED · NA
-
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
RECRUITING
-
Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)
ACTIVE NOT RECRUITING · Phase 2
-
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia